# Nutrition, Weight Gain, and Common Discomforts in Pregnancy
## Overview
Appropriate nutrition and weight gain in pregnancy are closely linked to optimal maternal and fetal outcomes. Both excess and insufficient weight gain increase the risk of complications including gestational diabetes, preeclampsia, macrosomia, preterm birth, and intrauterine growth restriction. The common discomforts of pregnancy are largely hormonally mediated and are managed primarily with reassurance and conservative measures.
## IOM Weight Gain Guidelines by Pre-Pregnancy BMI
| Pre-Pregnancy BMI | Category | Total Weight Gain (lbs) | Rate in 2nd/3rd Trimester (lbs/week) |
|-------------------|----------|------------------------|--------------------------------------|
| < 18.5 | Underweight | 28-40 | 1.0 (0.9-1.3) |
| 18.5-24.9 | Normal weight | 25-35 | 1.0 (0.8-1.0) |
| 25.0-29.9 | Overweight | 15-25 | 0.6 (0.5-0.7) |
| >= 30.0 | Obese | 11-20 | 0.5 (0.4-0.6) |
First-trimester weight gain is generally 1 to 4.4 pounds across all categories. For twin pregnancies, recommended total weight gain is 37 to 54 pounds for normal-weight women, 31 to 50 pounds for overweight women, and 25 to 42 pounds for obese women. No specific guidelines exist for Class III obesity (BMI 40 or greater); some experts suggest weight gain at the lower end of the obese range or even weight maintenance. Active weight loss during pregnancy is not recommended, though it may occur incidentally in obese patients who improve their dietary habits.
## Nutritional Requirements
### Caloric Needs
No additional calories are needed in the first trimester. The second trimester requires an additional 340 kcal per day above baseline, and the third trimester requires an additional 452 kcal per day. During lactation, an additional 330 to 400 kcal per day above the pregnancy baseline is needed. In total, pregnancy requires approximately 80,000 additional calories.
### Macronutrients
Protein requirements increase to 71 grams per day from the non-pregnant baseline of 46 grams per day. A minimum of 175 grams of carbohydrates per day is recommended. Fat should comprise 20 to 35% of total calories, with emphasis on omega-3 fatty acids (DHA at 200 to 300 mg per day). Fiber intake of 28 grams per day helps with constipation prevention.
### Key Micronutrients
| Nutrient | Daily Requirement | Clinical Significance |
|----------|-------------------|----------------------|
| Folic acid | 600 mcg (4 mg if high-risk for NTD) | Neural tube defect prevention |
| Iron | 27 mg | Blood volume expansion; prevent anemia |
| Calcium | 1000 mg | Fetal skeletal development; may reduce preeclampsia risk |
| Vitamin D | 600 IU (many experts recommend higher) | Bone health; immune function |
| Iodine | 220 mcg | Fetal thyroid development; neurocognition |
| Choline | 450 mg | Neural tube/brain development; often deficient |
| DHA | 200-300 mg | Fetal brain and retinal development |
| Vitamin B12 | 2.6 mcg | Important for vegan/vegetarian patients |
### Dietary Restrictions and Food Safety
Patients should avoid raw or undercooked meat, fish, and eggs, unpasteurized dairy, soft cheeses (due to Listeria risk), deli meats (unless heated to steaming), and raw sprouts. High-mercury fish -- including shark, swordfish, king mackerel, and tilefish -- should be avoided, with a maximum of 2 to 3 servings per week of low-mercury fish encouraged. Caffeine should be limited to less than 200 mg per day, roughly equivalent to one 12-ounce cup of coffee. No safe level of alcohol has been established, and complete abstinence is recommended. Among artificial sweeteners, aspartame and sucralose are generally considered safe, while saccharin crosses the placenta and is less preferred.
### Special Diets
Vegetarian and vegan patients require supplementation with B12, iron, calcium, DHA, and zinc, and may need additional protein counseling. Patients who have undergone bariatric surgery should be screened for nutritional deficiencies (B12, folate, iron, calcium, vitamin D, thiamine), advised to eat smaller and more frequent meals, and monitored closely for appropriate weight gain.
## Nausea and Vomiting of Pregnancy (NVP)
### Epidemiology and Pathophysiology
NVP affects 70 to 80% of pregnancies, typically beginning at 5 to 6 weeks, peaking at 9 weeks, and resolving by 16 to 20 weeks. The etiology is likely multifactorial, involving hCG-mediated mechanisms, estrogen and progesterone effects, and -- as emerging evidence suggests -- GDF15 (growth differentiation factor 15) as a key mediator. Despite the common name "morning sickness," symptoms occur throughout the day in most patients. Notably, NVP is associated with lower rates of miscarriage.
### Management Stepwise Approach
Management follows a stepwise escalation. The first step involves dietary modifications: small frequent meals, bland and dry foods, avoidance of triggers such as strong odors and fatty or spicy foods, ginger (250 mg four times daily), and protein-rich snacks. Vitamin B6 (pyridoxine) at 10 to 25 mg three times daily is the first-line pharmacotherapy. The combination of doxylamine and pyridoxine (marketed as Diclegis or Bonjesta) is the only FDA-approved medication for NVP, dosed at 10/10 mg up to four times daily. Antihistamines such as dimenhydrinate (25 to 50 mg every 6 hours) or diphenhydramine (25 to 50 mg every 6 hours) provide the next level of relief. Dopamine antagonists -- metoclopramide (5 to 10 mg every 8 hours) or promethazine (12.5 to 25 mg every 4 to 6 hours) -- can be added if needed. Ondansetron (4 mg every 8 hours) is effective but is considered second or third-line due to a small signal for cleft palate with first-trimester use, though this association remains debated. Corticosteroids such as methylprednisolone (16 mg every 8 hours, tapered) are reserved for refractory cases after 10 weeks, as they should be avoided before 10 weeks due to cleft lip and palate risk.
### Hyperemesis Gravidarum (HG)
Hyperemesis gravidarum represents severe NVP characterized by 5% or more pre-pregnancy weight loss, dehydration, ketonuria, and electrolyte abnormalities. It affects 0.3 to 3% of pregnancies. Evaluation should include electrolytes, BUN/creatinine, liver function tests, TSH (as transient hyperthyroidism from hCG can occur), urinalysis for ketones, and urine specific gravity.
Management centers on IV fluid resuscitation with normal saline or lactated Ringer's with dextrose, but thiamine (100 mg IV) must be given before dextrose-containing fluids to prevent Wernicke encephalopathy. Thiamine supplementation is particularly important when vomiting has been prolonged for more than three weeks. Antiemetic therapy follows the same stepwise approach as for NVP. The patient is kept NPO initially, then the diet is advanced as tolerated. Total parenteral nutrition or enteral feeding may be considered in rare refractory cases. Electrolytes must be monitored closely and repleted, particularly potassium, sodium, and magnesium. Complications of hyperemesis include Mallory-Weiss tears, Wernicke encephalopathy, hypokalemia, metabolic alkalosis, and intrauterine growth restriction.
## Common Discomforts and Evidence-Based Management
### Heartburn / Gastroesophageal Reflux
Heartburn affects 40 to 80% of pregnancies. It results from progesterone-mediated relaxation of the lower esophageal sphincter combined with mechanical compression by the growing uterus. Conservative management includes small frequent meals, avoiding lying down after eating, elevating the head of bed, and avoiding trigger foods. Pharmacotherapy options include antacids (calcium carbonate), H2 blockers (famotidine is preferred since ranitidine was withdrawn), and proton pump inhibitors (omeprazole, lansoprazole), which are generally considered safe.
### Constipation
Constipation affects approximately 40% of pregnancies. Progesterone slows gastrointestinal motility, and iron supplementation often exacerbates the problem. First-line management includes increasing fiber to 28 grams per day, ensuring adequate hydration, and exercising regularly. Pharmacotherapy includes docusate sodium as a stool softener, PEG 3350, and psyllium fiber. Stimulant laxatives such as bisacodyl and senna may be used short-term if constipation is refractory.
### Back Pain
Back pain affects 50 to 70% of pregnant patients, driven by lumbar lordosis, weight redistribution, and relaxin-mediated ligamentous laxity. Management includes proper posture, supportive footwear, a pelvic support belt, exercise (prenatal yoga and aquatic therapy work well), and heat application. Physical therapy referral is appropriate for persistent symptoms. Acetaminophen may be used for analgesia. NSAIDs should be avoided, especially after 20 weeks (due to oligohydramnios risk) and after 32 weeks (due to risk of premature ductus arteriosus closure).
### Round Ligament Pain
Round ligament pain presents as sharp, unilateral lower abdominal or inguinal pain with sudden movements, most commonly in the second trimester. Management consists of reassurance, gentle stretching, and acetaminophen as needed.
### Carpal Tunnel Syndrome
Carpal tunnel syndrome affects up to 60% of pregnant patients as a result of fluid retention compressing the median nerve. Night splinting and ergonomic modifications are first-line treatments. Symptoms typically resolve postpartum. Corticosteroid injection may be considered for severe cases.
### Lower Extremity Edema and Varicose Veins
Physiologic edema from increased blood volume and IVC compression is common. Compression stockings, leg elevation, and avoiding prolonged standing provide relief. Red flags requiring further evaluation include unilateral edema or calf tenderness (suggesting DVT) and facial or hand edema with hypertension (raising concern for preeclampsia).
### Hemorrhoids
Hemorrhoids develop from increased pelvic blood flow and constipation-related straining. Management focuses on treating constipation, warm sitz baths, topical witch hazel, and topical hydrocortisone or pramoxine preparations. A thrombosed external hemorrhoid may require excision.
A stepwise pyramid diagram showing the escalating management of nausea and vomiting in pregnancy. The base of the pyramid shows lifestyle and dietary modifications (small meals, ginger, acupressure bands). Moving upward: pyridoxine monotherapy, doxylamine-pyridoxine combination, antihistamines, dopamine antagonists, ondansetron, and at the apex, corticosteroids for refractory cases. On the right side, a parallel column shows hyperemesis gravidarum management with IV fluids, thiamine supplementation, and nutritional support. Each level includes dosing information.
An anatomical illustration showing the physiologic changes of pregnancy that contribute to common discomforts. A sagittal view of a pregnant woman at 30 weeks shows: (1) relaxed lower esophageal sphincter with reflux arrows for heartburn, (2) exaggerated lumbar lordosis with pain indicators for back pain, (3) compressed IVC from gravid uterus causing lower extremity edema, (4) stretched round ligaments labeled bilaterally, (5) slowed colonic motility with stool bulk in colon for constipation. Each structure is labeled with the causative hormonal or mechanical factor.
A clinical infographic showing the IOM weight gain guidelines. A central human figure silhouette is surrounded by four colored zones representing BMI categories (underweight, normal, overweight, obese). Each zone displays the recommended total weight gain range and weekly rate in the second and third trimesters. Below, a pie chart shows the physiologic distribution of pregnancy weight gain: fetus (7.5 lbs), placenta (1.5 lbs), amniotic fluid (2 lbs), uterine enlargement (2 lbs), breast tissue (2 lbs), blood volume (3 lbs), extravascular fluid (3 lbs), maternal fat stores (7 lbs).
## Key Clinical Pearls
Thiamine must always be given before dextrose-containing IV fluids in hyperemesis gravidarum to prevent Wernicke encephalopathy. Ondansetron is effective but is not first-line due to a small signal for orofacial clefts; pyridoxine-doxylamine should be tried first. Weight gain above IOM recommendations is associated with increased risk of macrosomia, cesarean delivery, and postpartum weight retention. GDF15 is emerging as a key mediator of NVP and hyperemesis gravidarum, and patients with chronically elevated GDF15 (such as thalassemia carriers) may be somewhat protected from NVP. NSAIDs should be avoided after 20 weeks due to the risk of fetal renal injury and oligohydramnios, per the 2020 FDA warning. Excessive weight gain in the first trimester is a predictor of total excess weight gain, making early counseling critical. Not all prenatal vitamins contain iodine -- the label should be checked and separate supplementation provided if needed.
## References
- ACOG Committee Opinion No. 804: Physical Activity and Exercise During Pregnancy and the Postpartum Period (2020)
- IOM (Institute of Medicine). Weight Gain During Pregnancy: Reexamining the Guidelines. National Academies Press, 2009
- ACOG Practice Bulletin No. 189: Nausea and Vomiting of Pregnancy (2018)
- Fejzo MS et al. GDF15 Linked to Maternal Risk of Nausea and Vomiting During Pregnancy. Nature. 2024;625:760-767
- FDA Drug Safety Communication: NSAIDs and Oligohydramnios (2020)